Researchers may have finally answered the question of why many antibodies that target the HIV envelope are still unable to stop the virus from spreading -- a troublesome stumbling block in the protracted search for an effective vaccine.
Slight variations in how those antibodies interact with their target on the HIV envelope cause conformational changes in the target molecule that render the antibodies ineffective, according to a study published this week in Science. This research "helps us to understand the molecular level details of [how certain antibodies bind] with better clarity than before," said viral immunologist linkurl:David Montefiore;http://humanvaccine.duke.edu/modules/montefiori/index.php?id=1 of Duke University, who was not involved in the work. "Understanding the atomic level [detail] that they [describe] here is very helpful for designing immunogens to elicit the right kinds of antibodies we want vaccines to elicit." In the hunt for an effective HIV...
Image: Wikimedia commons,
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?